#VisualAbstract: Methadone is a Better Treatment for Opioid Use Disorder than Buprenorphine/Naloxone

Click here to read this study in JAMA.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders

2 Minute Medicine: Pharma Roundup – Geopolitical instability in the Strait of Hormuz threatens global generic drug supply, daraxonrasib improves pancreatic cancer survival, sparsentan (Filspari) approved for focal segmental glomerulosclerosis, glucagon-like peptide-1 receptor agonists linked to reduced substance use disorders, and orforglipron (Foundayo) expands oral weight loss therapy options

Glucagon-like peptide-1 receptor agonists are associated with reduced risk of developing substance use disorders

#VisualAbstract: Methadone is a Better Treatment for Opioid Use Disorder than Buprenorphine/Naloxone

Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders

Glucagon-like peptide-1 receptor agonists are associated with reduced risk of developing substance use disorders

#VisualAbstract: Atrasentan Reduced Proteinuria in IgA Nephropathy

Novel colorectal cancer screening tests’ utility depends on patient context

RelatedReports

Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders

Glucagon-like peptide-1 receptor agonists are associated with reduced risk of developing substance use disorders

Higher dose extended-release buprenorphine may reduce opioid use in patients with heavy fentanyl use

Novel colorectal cancer screening tests’ utility depends on patient context

Weight loss interventions may improve metabolic and reproductive outcomes in polycystic ovarian syndrome

Machine learning algorithm shows limited capacity for reducing health spending for radiation therapy outpatients

Recent Reports